Patent · US Active

Kinase inhibitors and their uses

US8053434B2 · kind B2 · utility

4Cited by
1References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2009
Grant dateNov 8, 2011
Priority date
Expiry dateDec 11, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides compounds that inhibit protein kinases, such as JAK, Axl, or Syk kinases, compositions comprising the compounds and methods of using the compounds to inhibit protein kinase and treat and/or prevent diseases associated with inappropriate kinase activity. The compounds of the present invention are according to structural formula (I):or a salt or N-oxide thereof, whereinB is selected from

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.